...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience.
【24h】

Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience.

机译:双侧同步起搏预防药物难治性房性心律失常的长期效果:九年经验。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Results of previous studies suggest that atrial resynchronization by multisite atrial pacing may contribute to prevention of recurrences in patients with drug-refractory atrial tachyarrhythmias and significant intra-atrial conduction delay. METHODS AND RESULTS: To verify this hypothesis, a prospective noncontrolled study of 86 patients (mean age 66 +/- 10 years) was conducted in a single center between January 1989 and February 1998. Inclusion criteria were P wave duration > or = 120 msec with interatrial conduction time > or = 100 msec, and history of multiple recurrences of atrial tachyarrhythmias (mean 7 +/- 4.8 episodes) evolving in a persistent mode for at least 6 months despite optimized drug treatment (mean 2.7 +/- 1.8 drugs/patient). Patients were chronically implanted with a pacing system that ensured permanent biatrial pacing using two atrial leads, one placed in the high right atrium and the other one into the mid or the distal part of the coronary sinus. P wave duration decreased from a mean value of 187 +/- 29 msec before implant to 106 +/- 14 msec (P < 0.0001) under biatrial pacing. After a 33-month mean follow-up (range 6 to 109), 55 patients (64%) remained in sinus rhythm, including 28 patients (32.6%) without any documented recurrence and 27 patients with one or more recurrences in a paroxysmal or in a persistent form. In these 55 patients, drug treatment was significantly reduced in relation to the preimplantation period (1.4 +/- 0.6 vs 1.7 +/- 0.5 drugs/patient; P = 0.011). The other 31 patients went into chronic atrial arrhythmia after a mean period of 26 months. The only predictive factor of positive response was a spontaneous P wave duration < 160 msec at baseline. CONCLUSION: The results are consistent with a preventive effect of permanent biatrial pacing on recurrent and drug-refractory atrial arrhythmias associated with intra-atrial conduction delay.
机译:简介:先前的研究结果表明,通过多部位心房起搏进行心房再同步可能有助于预防药物难治性房速性心律失常和明显的房内传导延迟的患者复发。方法和结果:为证实这一假设,于1989年1月至1998年2月在一个中心进行了86位患者(平均年龄66 +/- 10岁)的前瞻性非对照研究。纳入标准为P波持续时间>或= 120毫秒房间传导时间>或= 100毫秒,并且尽管优化了药物治疗,但多次持续性房速性心律失常的病史(平均7 +/- 4.8次发作)持续发展至少6个月(平均2.7 +/- 1.8药患者)。患者被长期植入起搏系统,该系统使用两根心房导线确保永久性双心起搏,一根导线放置在右上心房,另一根导线插入冠状窦的中部或远端。 P波持续时间从植入前的平均值187 +/- 29毫秒降低到双耳起搏下的106 +/- 14毫秒(P <0.0001)。在平均随访33个月(范围从6到109)之后,仍有55例患者(64%)保持窦性心律,其中28例(32.6%)无复发记录,另有27例阵发性或复发性复发。以持久的形式。在这55名患者中,药物治疗相对于植入前期明显减少(1.4 +/- 0.6与1.7 +/- 0.5药物/患者; P = 0.011)。平均31个月后,其他31例患者进入了慢性心律失常。阳性反应的唯一预测因素是基线时自发的P波持续时间<160毫秒。结论:该结果与永久性二尖瓣起搏对与房内传导延迟相关的复发性和难治性房性心律失常的预防作用一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号